Header cover image

U.S. Pharmaceuticals & Biotech High Risk Large Caps

Results

2

1 new

Are you holding one of these? A list of some of the most volatile large-cap stocks over the past five years.

2 companies

Natera

Market Cap: US$20.5b

A diagnostics company, provides molecular testing services worldwide.

NTRA

US$143.28

7D

3.3%

1Y

48.2%

Moderna

Market Cap: US$10.3b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

New

MRNA

US$24.50

7D

-4.8%

1Y

-77.1%